Skip to main content

Sarcopenia in a patient with most serious complications after highly invasive surgeries treated with nutrition, rehabilitation, and pharmacotherapy: a case report

Abstract

Background

Several studies have reported the implementation of nutrition therapy and rehabilitation for acute and critical illnesses. However, rehabilitation nutrition for elderly sarcopenia patients with extremely severe postoperative complications during hospitalization has not yet been established.

Case presentation

We report the case of a 70-year-old man with sarcopenia that developed as a postoperative complication of the surgical resection of perihilar cholangiocarcinoma and left the patient bedridden from prolonged malnutrition and muscle weakness. The patient’s general condition improved after a nearly 6-month intervention by our Nutrition Support Team (NST) that combined nutrition, exercise, and pharmacotherapy.

Conclusions

The appropriate timing and order of pharmacotherapy, nutrient administration, exercise therapy, and team collaboration may enable elderly patients with severe (secondary) sarcopenia and postoperative complications to regain self-sustained walking.

Background

Elderly patients are at an increased risk of sarcopenia and postoperative complications after highly invasive surgeries [1]. In addition, they are prone to muscle strength loss due to inactivity [2] and malnourishment during hospitalization [3]. Surgery for perihilar cholangiocarcinoma is a particularly invasive type of gastrointestinal surgery with a high rate of perioperative complications. The morbidity rates after surgery are high because it is more likely to present added potential risk factors, such as obstructive jaundice with or without cholangitis [4] [5]. Malnutrition is associated with adverse perioperative outcomes [6]. Patients recovering from severe illnesses may experience significant muscle mass loss. In a previous randomized controlled trial, Jones et al. [7] reported that enhanced physiotherapy, structured exercise, and amino acid supplementation (including glutamine) may aid physical recovery in elderly patients recovering from a prolonged period of illness. Patients with intensive care unit stay of 5 days or more were recruited in those study. However, participants were excluded if they had renal failure (requiring regular dialysis). Hegerova et al. [8] also reported that early nutritional supplements and early physiotherapy preserve muscle mass and independence in elderly patients hospitalized for acute disease. However, lean body mass (LBM) progression was only − 0.4 kg during the 6-month period in this study group. The factors contributing to both trial outcomes, physical recovery, and muscle mass remain unclear. We report the case of an elderly bedridden patient with secondary sarcopenia who developed postoperative complications including acute kidney injury (AKI) (requiring dialysis) and hepatic failure. The patient’s LBM and general condition greatly improved after a 6-month intervention by Nutrition Support Team (NST). We will discuss some potential factors contributing to favorable outcomes in our case.

Case presentation

Patient

The patient was a 70-year-old man with a history of cerebral infarction (no paralysis), hypertension, and duodenal ulcers; he had no history of allergies. On admission, he was independently ambulatory. The Eastern Cooperative Oncology Group Performance Status (ECOG PS; range, 0–4; with higher scores indicating worse disability) was 0 [9]. Serum transferrin, pre-albumin, and retinol-binding protein levels were 237 mg/dL (range: 190–300), 23.4 mg/dL (range: 22–40), and 1.90 mg/dL (range: 3.6–4.2), respectively, before the operation. He underwent resection of the right and caudate lobes of the liver, extrahepatic bile duct resection, choledochojejunostomy, and jejunostomy for perihilar cholangiocarcinoma.

Need for intervention

During the first 3 months after the operation, the patient experienced hepatic failure, AKI, disseminated intravascular coagulation (DIC), and pneumonia. Hemodialysis was performed three times per week. The patient was bedridden for the entire day, and his ECOG PS was 3–4. The enteral tube was placed in the jejunum to administer medicine and nutrition; however, enteral nutrition was stopped repeatedly owing to the worsening of postoperative complications or gastrointestinal symptoms. Consequently, he received both parenteral and enteral nutrition with a total energy of 1200 kcal/day and 25.0 g/day protein. Physical findings and serum levels related to renal function are shown in Table 1. When his body composition was analyzed using the InBody® (Inbody S20; Biospace, Seoul, Korea) system, the skeletal muscle mass, skeletal muscle mass index (SMI), fat mass, body fat, and extracellular water (ECW) to total body water (TBW) ratio were 14.2 kg, 5.85 kg/m2, 19.4 kg, 39.0%, and 0.436, respectively. The patient had edema, ascites, and a pleural effusion. His dry weight estimated by subtracting the excess fluid from the actual body weight was 47.0 kg; the patient lost 10.0 kg in about 5 months. He met the diagnostic criteria for sarcopenia by the Asian Working Group for Sarcopenia (AWGS) [10] and was classified as severely malnourished. He underwent repeated cycles of constipation and diarrhea.

Table 1 Physical findings and serum levels related to renal function

Intervention goals

The target energy intake was set at 35.0 kcal/kg/day (1700 kcal/day). The target protein intake was 1.20 g/kg/day (60.0 g/day) and 0.80 g/kg/day (40.0 g/day) when on and off dialysis, respectively, based on the consensus among the NST, the nephrologist, and the gastrointestinal surgeon, and consistent with the 2016 Clinical Practice Guideline for Acute Kidney Injury in Japan [11] and recommendation of the third revision (2013) of the guidelines for parenteral and enteral nutrition in Japan [12]. The use of intravenous- and enteral-nutrition routes was evaluated continuously. The patient was assessed as having AKI which gradually improved but transitioned from acute to chronic kidney disease. The nephrologist assessed the need for weekly hemodialysis, which the patient received as needed. Priority was given to patient mobilization, balance of energy intake and expenditure, prevention of complications associated with bed rest, and prevention of the progression of generalized deconditioning.

Clinical course

The patient was fed via a combination of total parenteral nutrition, peripheral parenteral nutrition, and enteral nutrition; blood-glucose levels were monitored. We evaluated the patient’s physical findings, renal function test values (Table 1) and adjusted laxative prescriptions to improve bowel movements. Dialysis was stopped on day 56. On day 112 of the NST intervention, the protein dose was 1.40 g/kg/day, and the energy and protein doses were stabilized. The intake of essential nutrients was sufficient with continuous enteral nutrition alone at a slow rate throughout the day (Table 2).

Table 2 Composition of the administered solutions

The patient’s limbs were strong enough to perform activities of daily living (ADL) in bed, so upper body muscle training was started 5 days a week for 20 min. The aim of this training was to extend the sitting time on the bed and to acquire ADL-movement ability. Moreover, lower-limb muscle training was initiated to prevent the loss of skeletal muscle. As the patient’s nutritional status improved, the proportion of strength training in the regimen was gradually increased. The patient was able to stand unassisted on day 100 of the intervention; hence, walking training was started.

Renalen®MP was administered via an enteral route as an energy-dense nutrition formula to meet the target energy goals. Furthermore, we added branched-chain amino acids (BCAA)-enriched nutritional supplements (i.e., ENEVO® and Aminoleban®EN) because they are expected to promote protein synthesis [13]. Initially, Renalen®MP was administered during the daytime, and the patient frequently complained of gastroesophageal reflux and bloating during tube feeding, probably because of the high fat content in Renalen®MP. Because of these complaints, it was difficult for him to continue rehabilitation. Therefore, we changed the time of administration of Renalen®MP from daytime to nighttime (Table 2). The patient was able to walk independently on day 150. He could also ingest a small amount of food orally. On day 200, the skeletal-muscle mass, SMI, fat mass, body fat, and ECW/TBW ratio were 19.1 kg, 7.95 kg/m2, 17.6 kg, 31.4%, and 0.436, respectively. The ECOG PS was 2. The rehabilitation was continued, so that the patient could be discharged.

Outcomes

The patient was able to receive daily nutrition both enterally and orally. The dynamic nutritional-assessment parameters and brachial muscle analysis increased over time (Figs. 13). Body weight and LBM slightly decreased by day 103 but increased after day 103. On day 200, they have improved to what it was almost before the surgery (Fig. 2). He continued rehabilitation because his bowel movements were controlled.

Fig. 1
figure1

Serum levels of retinol binding protein (mg/dL), Pre albumin (mg/dL), and transferrin (mg/dL) from Day 1 to Day 112

Fig. 2
figure2

Body weight and muscle-fat analysis measured by InBody® on days 1, 5, 103, and 200

Discussion and conclusions

During severe illness and comorbidity, skeletal muscle and function are lost. Muscle mass is determined by the balance between protein synthesis and breakdown. Exercise and BCAA (particularly leucine) increase protein synthesis by upregulating the anabolic pathway that promotes intramuscular protein synthesis [14]. Kim et al. found that exercise and amino acid supplementation together may be effective in enhancing not only muscle strength but also combined variables of muscle mass, walking speed, and strength in sarcopenic women [15]. In our patient, despite the initiation of physical training immediately after the surgery, muscle mass did not improve until nutrition intervention, as he had a lack of nutrition. This finding was in accordance with those of previous studies [15, 16]. At the time of muscle protein catabolism, the physiotherapist tried to maintain ADL and muscle strength without increasing the exercise load until the required energy was administered. Therefore, the activity level was intentionally set to the sitting position. The patient performed strength training mainly while sitting to maintain physical function, but not for muscle hypertrophy. Moreover, the training encouraged voluntary ADL. Strength training required for each movement was performed continuously since the intervention. As the patient’s nutritional status improved, we gradually increased the proportion of strength training in the regimen. On day 100, he was able to stand unassisted; therefore, we initiated walking training. He was able to walk from his bedroom to a nurse’s station and back independently by day 150.

Jones et al. [7] did not report the total energy, total protein intake, findings, or muscle strength. Regarding the outcome data, a systematic review judged a high risk of bias due to a lack of power and follow-up for over 20% of the participants [17]. In the study by Hagerova et al. [8], participants were excluded if they had weight loss recently. The length of hospital stay for all patients was 11 ± 7 days, and nutritional intake was tolerated during hospitalization. LBM did not change markedly in the intervention group. Two RCTs [7, 8] were premised on restarting oral intake after admission [17]. In our patient, LBM improved from 29.7 kg to 38.3 kg. It was considered that appropriate and continuous training as well as nutrition focused on catabolism and anabolism enabled improvement of his physical strength.

Liquids that contain fats are reportedly emptied from the stomach more slowly than liquids that do not contain fats because the presence of fat causes secretion of cholecystokinin [18]. In contrast, dietary proteins with any amino-acid composition are processed by the stomach at the same speed regardless of whether they are amino acids, peptides, or polypeptides [19]. Aminoleban®EN is lower in fat (0.925 g per hour) than Renalen®MP (2.4 g per hour) and ENEVO® (1.6 g per hour). His gastrointestinal symptoms diminished enough to enable the continuation of rehabilitation after the order of administration time of nutrition was changed as Table 2.

Our patient experienced complications such as multiple organ failure, including an AKI meeting the Kidney Disease: Improving Global (KDIGO) diagnostic criteria [20], DIC, and chronic kidney disease; further, he had been repeatedly admitted to the intensive care units. Before the intervention by NST, the patient showed persistently suppressed adaptive immunity and low-grade inflammation indicating accelerated protein catabolism [21]. In Japan, it was used as a standard practice to restrict protein intake in patients with renal impairment regardless of the severity of the condition. However, this changed with the publication of the Clinical Practice Guideline for AKI in Japan [11]. Clinical Practice Guideline for AKI [11] suggest the target energy intake and dose of protein depend on the severity and identity of the underlying disease. NST, the nephrologist, and the gastrointestinal surgeons decided that the first goal should be to control inflammation and dialysis-induced protein catabolism. Therefore, the target protein intake was set as 1.20 g/kg/day (60.0 g/day) and 0.80 g/kg/day (40.0 g/day) when on and off dialysis, respectively. The nephrologist assessed the need for weekly dialysis and gastrointestinal surgeons evaluated nutritional prescriptions according to the patient’s symptoms and test results every 3 days or 1 week until the dialysis was completely stopped, and inflammation reduced.

The effect of exercise on nutritional status and body composition has been reported previously [22]. Nutritional rehabilitation in critically ill patients on and after intensive care units is difficult [23]. Recovery from moderate to severe AKI is heterogeneous and can take up to several months [24]. A previous study reported that LBM was significantly low in hemodialysis patients, and hemodialysis increased protein breakdown [25]. Therefore, it is important to recover from dialysis for effective nutrition. In our case, a pharmacist monitored the prescribed medications to prevent renal injury. A registered dietitian and pharmacist checked the protein intake and renal function every week until dialysis was stopped. At the time of anabolism, protein intake gradually increased to 1.40 g/kg/day.

Three points should be considered in this case: First, the InBody®-measurement results were reference values because the impedance was reversed. The ECW/TBW was over 0.4 suggesting ascites retention due to postoperative liver failure and fluid retention due to AKI. Therefore, the InBody® measurement may not be accurate. Body weight and LBM gradually decreased by day 103 (Fig. 2). However, the arm circumference, arm muscle circumference, and triceps skin folds increased over time (Fig. 3). This seems to be due to recovered renal function from improved postoperative complications, and the edema and ascites were reduced. Second, the Asian Working Group for Sarcopenia requires a decrease in the SMI and grip strength or walking speed to define sarcopenia. In this case, the grip strength and walking speed were measured before the operation but could not be measured after the operation. Third, the measurement of protein catabolism biomarkers was not performed. Therefore, we evaluated the time of anabolism when serum concentrations of C-reactive proteins were below 4 mg/dL [26].

Fig. 3
figure3

Brachial muscle analysis. The arm circumference (standard value: 26.8 cm), arm muscle circumference (standard value: 23.6 cm), and triceps skin folds (standard value: 10.0 mm) on days 5, 105, and 200. The standard value is based by the Japanese Anthropometric Reference Data 2001

Our patient with prolonged malnutrition due to postoperative complications was treated by initiating a 6-month-long NST intervention that combined nutrition, exercise therapy, and pharmacotherapy. The results demonstrated that the appropriate timing of nutritional counseling, exercise therapy, and team collaboration can enable elderly patients with severe (secondary) sarcopenia due to postoperative complications to recover and regain self-sustained walking.

Availability of data and materials

Data sharing does not apply to this article as no datasets were generated or analyzed during the current study.

Abbreviations

ADL:

Activities of daily living

AKI:

Acute kidney injury

BCAA:

Branched-chain amino acids

DIC:

Disseminated intravascular coagulation

ECOG PS:

Eastern Cooperative Oncology Group performance status

ECW:

Extracellular water

LBM:

Lean body mass

NST:

Nutrition support team

SMI:

Skeletal muscle mass index

TBW:

Total body water

References

  1. 1.

    Feng MA, McMillan DT, Crowell K, Muss H, Nielsen ME, Smith AB. Geriatric assessment in surgical oncology: a systematic review. J Surg Res. 2015;193:265–72. https://doi.org/10.1016/j.jss.2014.07.004.

    Article  PubMed  Google Scholar 

  2. 2.

    Ali S, Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology. 2014;60:294–305.

    CAS  Article  Google Scholar 

  3. 3.

    Kojima G. Frailty as a predictor of hospitalisation among community-dwelling older people: a systematic review and meta-analysis. J Epidemiol Community Health. 2016;70:722–9. https://doi.org/10.1159/000356760.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Farges O, Regimbeau JM, Fuks D, Le Treut YP, Cherqui D, Bachellier P, et al. Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma. Br J Surg. 2013;100(2):274–83. https://doi.org/10.1002/bjs.8950.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Dokmak S, Fteriche FS, Borscheid R, Cauchy F, Farges O, Belghiti J. 2012 Liver resections in the 21st century: we are far from zero mortality: HPB) Oxford).2013;15(11):908-15. doi: https://doi.org/10.1111/hpb.12069.

  6. 6.

    Norman K, Pichard C, Lochs H, Pirlich M. Prognostic impact of disease-related malnutrition. Clin Nutr. 2008;27:5–15. https://doi.org/10.1016/j.clnu.2007.10.007.

    Article  PubMed  Google Scholar 

  7. 7.

    Jones C, Eddleston J, McCairn A, Dowling S, McWilliams D, Coughlan E, Griffiths RD. Improving rehabilitation after critical illness through outpatient physiotherapy classes and essential amino acid supplement: a randomized controlled trial. J Crit Care. 2015;30(5):901–7. https://doi.org/10.1016/j.jcrc.2015.05.002.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Hegerová P, Dědková Z, Sobotka L. Early nutritional support and physiotherapy improved long-term self-sufficiency in acutely ill older patients. Nutrition. 2015;31(1):166–70. https://doi.org/10.1016/j.nut.2014.07.010.

    Article  PubMed  Google Scholar 

  9. 9.

    Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol. 1982;5(6):649–55.

    CAS  Article  Google Scholar 

  10. 10.

    Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. https://www.jamda.com/article/S1525-8610(19)30872-2/fulltext. Accessed 2/2021.

  11. 11.

    Japanese Society of Nephrology. Clinical practice guideline for acute kidney injury. 2016. https://cdn.jsn.or.jp/guideline/pdf/419-533.pdf (in Japanese). Accessed 2/2021.

    Google Scholar 

  12. 12.

    Japanese Society for Clinical Nutrition and Metabolism. The third revision of the guidelines for parenteral and enteral nutrition. 2013. https://minds.jcqhc.or.jp/docs/minds/PEN/Parenteral_and_Enteral_Nutrition.pdf (in Japanese). Accessed 2/2021.

    Google Scholar 

  13. 13.

    McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (a.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016;40:159–211.

    CAS  Article  Google Scholar 

  14. 14.

    Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3:1014–9. https://doi.org/10.1038/ncb1101-1014.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Kim HK, Suzuki T, Saito K, et al. Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial. J Am Geriatr Soc. 2012;6. https://doi.org/10.1111/j.1532-5415.2011.03776.x.

  16. 16.

    Denison HJ, Cooper C, Sayer AA, Robinson SM. Prevention and optimal management of sarcopenia: a review of combined exercise and nutrition interventions to improve muscle outcomes in older people. Clin Interv Aging. 2015;10:859–69. https://doi.org/10.2147/CIA.S55842.

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Kou K, Momosaki R, Miyazaki S, Wakabayashi H, Shamoto H. Impact of nutrition therapy and rehabilitation on acute and critical illness: a systematic review. J UOEH. 2019;41(3):303–15. https://doi.org/10.7888/juoeh.41.303.

    Article  PubMed  Google Scholar 

  18. 18.

    Mathus-Vliegen EM, van Ierland-van Leeuwen ML, Bennink RJ. Influences of fat restriction and lipase inhibition on gastric emptying in obesity. Int J Obes. 2006;30:1203–10. https://doi.org/10.1038/sj.ijo.0803255.

    CAS  Article  Google Scholar 

  19. 19.

    Calbet JA, Holst JJ. Gastric emptying, gastric secretion and enterogastrone response after administration of milk proteins or their peptide hydrolysates in humans. Eur J Nutr. 2004;43:127–39. https://doi.org/10.1007/s00394-004-0448-4.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2012. https://kdigo.org/guidelines/acute-kidney-injury/. Accessed 2/ 2021.

  21. 21.

    Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491–501. https://doi.org/10.1097/ta.0b013e318256e000.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Bakaloudi DR, Siargkas A, Poulia KA, Dounousi E, Chourdakis M. The effect of exercise on nutritional status and body composition in hemodialysis: a systematic review. Nutrients. 2020;12(10):3071. https://doi.org/10.3390/nu12103071.

    CAS  Article  PubMed Central  Google Scholar 

  23. 23.

    Schefold JC, Wollersheim T, Grunow JJ, Luedi MM, Z'Graggen WJ, Weber-Carstens S. Muscular weakness and muscle wasting in the critically ill. J Cachexia Sarcopenia Muscle. 2020;11(6):1399–412. https://doi.org/10.1002/jcsm.12620.

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Siew ED, Abdel-Kader K, Perkins AM, Greevy RA Jr. Timing of recovery from moderate to severe AKI and the risk for future loss of kidney function. Am J Kidney Dis. 2020;75(2):204–13. https://doi.org/10.1053/j.ajkd.2019.05.031.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Lim VS, Ikizler TA, Raj DS, Flanigan MJ. Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics. J Am Soc Nephrol. 2005;16(4):862–8. https://doi.org/10.1681/ASN.2004080624.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    Cederholm T, Barazzoni R, Austin P, Ballmer P, Biolo G, Bischoff SC, Compher C, Correia I, Higashiguchi T. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr. 2017;36(1):49–64. https://doi.org/10.1016/j.clnu.2016.09.004.

    CAS  Article  Google Scholar 

Download references

Acknowledgments

Not applicable.

Funding

No funding was received for this study.

Author information

Affiliations

Authors

Contributions

MT treated the patient, drafted the manuscript, and contributed to data interpretation. SK, TA, and SM treated the patient, revised the manuscript, and contributed to data interpretation. HT and TS revised the manuscript and contributed to data interpretation. YW, SK, SH, and AH contributed to data interpretation. YT revised the manuscript and contributed to data interpretation. MS supervised the entire report preparation and completed the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Mitsuru Sugawara.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tatsumi, M., Kumagai, S., Abe, T. et al. Sarcopenia in a patient with most serious complications after highly invasive surgeries treated with nutrition, rehabilitation, and pharmacotherapy: a case report. J Pharm Health Care Sci 7, 16 (2021). https://doi.org/10.1186/s40780-021-00197-9

Download citation

Keywords

  • Sarcopenia
  • Postoperative
  • Nutrition therapy
  • Exercise
  • Pharmacotherapy
  • Total parenteral nutrition
  • Branched-chain amino acids (BCAA)
  • Rehabilitation
\